LEI-101 is a potent, selective, orally bioavailable cannabinoid CB2 receptor agonist used in research to investigate CB2-mediated signaling and pharmacology. It exhibits approximately 100-fold selectivity for CB2 over CB1, with a pEC50 of about 8 for human CB2, low hERG affinity, and is supplied as a high-purity white to off-white solid suitable for in vitro and in vivo studies.
- High purity (99.4%).
- Potent CB2 agonist (pEC50 ≈ 8 for hCB2).
- Approximately 100-fold selectivity for CB2 over CB1.
- Low hERG binding (pKi < 4).
- Soluble in DMSO (≈116.67 mg/mL).
- Stable when stored sealed and kept away from moisture; in solvent: -80°C (6 months), -20°C (1 month).
- Provided in milligram-scale quantities for research use.